GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » New China Life Insurance Co Ltd (HKSE:01336) » Definitions » Research & Development

New China Life Insurance Co (HKSE:01336) Research & Development : HK$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is New China Life Insurance Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. New China Life Insurance Co's Research & Development for the three months ended in Mar. 2024 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0 Mil.


New China Life Insurance Co Research & Development Historical Data

The historical data trend for New China Life Insurance Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New China Life Insurance Co Research & Development Chart

New China Life Insurance Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

New China Life Insurance Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

New China Life Insurance Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New China Life Insurance Co  (HKSE:01336) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


New China Life Insurance Co Research & Development Related Terms

Thank you for viewing the detailed overview of New China Life Insurance Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


New China Life Insurance Co (HKSE:01336) Business Description

Traded in Other Exchanges
Address
A12 Jianguomenwai Avenue, New China Insurance Tower, Chaoyang District, Beijing, CHN, 100022
Headquartered in Beijing, New China Life Insurance, or NCI, was founded by SOEs and private firms in 1996. The company is the fourth-largest life insurer in China in terms of total assets. Huijin Investment, the government's investment company owns 31% shares of New China Life. The company was listed on the Hong Kong and Shanghai Stock Exchanges in 2011. New China Life offers comprehensive life insurance products and services to individual customers and institutional customers through nationwide distributional networks and diversified marketing channels, manages and deploys insurance funds through its subsidiaries, including Asset Management Company and Asset Management Company (Hong Kong).

New China Life Insurance Co (HKSE:01336) Headlines

No Headlines